Ursodeoxycholic acid in complex treatment of patients with a metabolic syndrome

被引：0

作者：

Tanchenko, O. A. ^{[1
]}

Naryshkina, S. V. ^{[1
]}

机构：

[1] Amur State Med Acad, Blagoveshchensk, Russia

来源：

YAKUT MEDICAL JOURNAL | 2010年 / 04期

关键词：

metabolic syndrome; ursodeoxycholic acid; immunoreactive insulin; leptin; gamma-glutamyl transpeptidase; triglycerides;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Patients with metabolic syndrome who got ursodeoxycholic acid in complex treatment were examined. The indices of immunoreactive insulin, leptin were studied in dynamics with the use of immunoenzymatic method, the values of lipid spectrum, the data of ultrasound investigation of liver were determined. It was revealed that inclusion of ursodeoxycholic acid into the complex treatment of patients with metabolic syndrome lead to the decrease of indices of immunoreactive insulin, leptin, atherogenic fractions of lipids playing a leading role in the development and progressing of metabolic syndrome.

引用

页码：38 / 40

页数：3

共 50 条

[1] TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH METABOLIC SYNDROME USING SIMVASTATIN AND URSODEOXYCHOLIC ACID
Drapkina, O. M.
Ivashkin, V. T.
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 154 - 154
[2] The treatment with Ursodeoxycholic Acid in elderly patients affected by NAFLD and Metabolic Syndrome: A case-control study
Troisi, G.
Crisciotti, F.
Gianturco, V.
D'Ottavio, E.
Lo Iacono, C.
Formosa, V.
Bernardini, S.
Bellomo, A.
Marigliano, B.
Marigliano, V.
[J]. CLINICA TERAPEUTICA, 2013, 164 (03): : 203 - 207
[3] SIMVASTATIN AND URSODEOXYCHOLIC ACID IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME
Korneeva, O. N.
Drapkina, O. M.
Ivashkin, V. T.
[J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S146 - S146
[4] Treatment of vanishing bile duct syndrome with ursodeoxycholic acid
Podda, M
Crosignani, A
Larghi, A
Battezzati, PM
Invernizzi, P
Allocca, M
Zuin, M
[J]. VANISHING BILE DUCT SYNDROME - PATHOPHYSIOLOGY AND TREATMENT, 1997, 91B : 224 - 229
[5] URSODEOXYCHOLIC ACID TREATMENT OF PRIMARY HEPATOLITHIASIS IN CAROLIS SYNDROME
ROS, E
NAVARRO, S
BRU, C
GILABERT, R
BIANCHI, L
BRUGUERA, M
[J]. LANCET, 1993, 342 (8868): : 404 - 406
[6] TREATMENT OF CHOLESTEROL GALLSTONE PATIENTS WITH URSODEOXYCHOLIC ACID
MARZIO, L
[J]. GASTROENTEROLOGY, 1991, 101 (01) : 275 - 276
[7] Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats
Mahmoud, Amr A. A.
Elshazly, Shimaa M.
[J]. PLOS ONE, 2014, 9 (09):
[8] Depressive disorders and their correction in complex treatment of metabolic syndrome patients
Uspensky, Yu. P.
Balukova, E. V.
[J]. CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (03): : 33 - +
[9] Histopathologic and metabolic effect of ursodeoxycholic acid treatment on PCOS rat model
Gozukara, Ilay
Dokuyucu, Recep
Ozgur, Tumay
Ozcan, Oguzhan
Pinar, Neslihan
Kurt, Raziye Keskin
Kucur, Suna Kabil
Dolapci, Kenan
[J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (06) : 492 - 497
[10] TREATMENT OF CHOLESTEROL GALLSTONE PATIENTS WITH URSODEOXYCHOLIC ACID - REPLY
RODA, E
FESTI, D
BAZZOLI, F
[J]. GASTROENTEROLOGY, 1991, 101 (01) : 276 - 276

← 1 2 3 4 5 →